| Literature DB >> 34273798 |
Harri Sivasathiaseelan1, Charles R Marshall2, Elia Benhamou3, Janneke E P van Leeuwen3, Rebecca L Bond3, Lucy L Russell3, Caroline Greaves3, Katrina M Moore3, Chris J D Hardy3, Chris Frost4, Jonathan D Rohrer3, Sophie K Scott5, Jason D Warren3.
Abstract
Laughter is a fundamental communicative signal in our relations with other people and is used to convey a diverse repertoire of social and emotional information. It is therefore potentially a useful probe of impaired socio-emotional signal processing in neurodegenerative diseases. Here we investigated the cognitive and affective processing of laughter in forty-seven patients representing all major syndromes of frontotemporal dementia, a disease spectrum characterised by severe socio-emotional dysfunction (twenty-two with behavioural variant frontotemporal dementia, twelve with semantic variant primary progressive aphasia, thirteen with nonfluent-agrammatic variant primary progressive aphasia), in relation to fifteen patients with typical amnestic Alzheimer's disease and twenty healthy age-matched individuals. We assessed cognitive labelling (identification) and valence rating (affective evaluation) of samples of spontaneous (mirthful and hostile) and volitional (posed) laughter versus two auditory control conditions (a synthetic laughter-like stimulus and spoken numbers). Neuroanatomical associations of laughter processing were assessed using voxel-based morphometry of patients' brain MR images. While all dementia syndromes were associated with impaired identification of laughter subtypes relative to healthy controls, this was significantly more severe overall in frontotemporal dementia than in Alzheimer's disease and particularly in the behavioural and semantic variants, which also showed abnormal affective evaluation of laughter. Over the patient cohort, laughter identification accuracy was correlated with measures of daily-life socio-emotional functioning. Certain striking syndromic signatures emerged, including enhanced liking for hostile laughter in behavioural variant frontotemporal dementia, impaired processing of synthetic laughter in the nonfluent-agrammatic variant (consistent with a generic complex auditory perceptual deficit) and enhanced liking for numbers ('numerophilia') in the semantic variant. Across the patient cohort, overall laughter identification accuracy correlated with regional grey matter in a core network encompassing inferior frontal and cingulo-insular cortices; and more specific correlates of laughter identification accuracy were delineated in cortical regions mediating affective disambiguation (identification of hostile and posed laughter in orbitofrontal cortex) and authenticity (social intent) decoding (identification of mirthful and posed laughter in anteromedial prefrontal cortex) (all p < .05 after correction for multiple voxel-wise comparisons over the whole brain). These findings reveal a rich diversity of cognitive and affective laughter phenotypes in canonical dementia syndromes and suggest that laughter is an informative probe of neural mechanisms underpinning socio-emotional dysfunction in neurodegenerative disease.Entities:
Keywords: Alzheimer's disease; Authenticity; Frontotemporal dementia; Laughter; Numerophilia; Progressive aphasia; Social cognition; Vocal emotion
Mesh:
Year: 2021 PMID: 34273798 PMCID: PMC8438290 DOI: 10.1016/j.cortex.2021.05.020
Source DB: PubMed Journal: Cortex ISSN: 0010-9452 Impact factor: 4.027
Demographic, clinical and general neuropsychological characteristics of participant groups.
| Characteristic | Controls | AD | nfvPPA | svPPA | bvFTD |
|---|---|---|---|---|---|
| No. (male:female) | 12:8 | 8:7 | 7:6 | 7:5 | 16:6 |
| Age (years) | 65.3 (6.3) | 70.8 (6.2) | 69.3 (10.0) | 66.8 (7.2) | 66.5 (6.2) |
| Handedness (right:left) | 19:1 | 13:2 | 12:1 | 12:0 | 21:1 |
| Education (years) | 14.8 (3.1) | 14.1 (2.5) | 12.9 (2.4) | 13.4 (2.5) | 14.3 (3.0) |
| MMSE (/30) | 29.5 (.9) | ||||
| Symptom duration (years) | N/A | 6.9 (2.9) | 4.9 (1.3) | 7.1 (2.4) | 7.0 (3.0) |
| Genetic mutations (no.) | N/A | 0 | 2 | 0 | 4 |
| No. taking donepezil | 0 | 10 | 0 | 0 | 0 |
| No. taking antidepressants | 0 | 7 | 4 | 4 | 7 |
| Audiometry score | 26.3 (5.1) | 30.7 (6.8) | 29.5 (6.8) | 27.7 (6.1) | 32.2 (7.7) |
| RMT words (/50) | 48.3 (2.0) | ||||
| RMT faces (/50) | 42.5 (5.3) | ||||
| WASI Matrices (/32) | 25.7 (4.2) | 25.8 (4.7) | |||
| D-KEFS Stroop: | |||||
| colour naming (s) | 29.6 (5.5) | ||||
| word reading (s) | 22.1 (4.6) | 34.7 (12.2) | 29.5 (15.2) | ||
| interference (s) | 57.3 (17.8) | ||||
| Trails A (s) | 27.1 (6.1) | 49.0 (18.5) | 54.1 (36.2) | ||
| Trails B (s) | 67.2 (29.9) | 168.5 (100.1) | |||
| WASI vocabulary (/80) | 70.1 (4.9) | ||||
| BPVS (/150) | 147.4 (1.0) | 124.5 (29.2) | 122.4 (41.5) | ||
| GNT (/30) | 25.1 (2.8) | ||||
| WASI Block Design (/71) | 47.3 (12.4) | 38.8 (17.3) | |||
| GDA (/24) | 15.9 (4.9) | 12.1 (5.6) | |||
| VOSP Object Decision (/20) | 18.2 (1.3) | 15.7 (3.0) | 15.4 (3.1) | 15.6 (3.7) | |
Mean (standard deviation) values are shown unless otherwise indicated; scores that are statistically significantly different from healthy controls are shown in bold (maximum scores for neuropsychological tests are in parentheses).
AD, patient group with typical Alzheimer's disease; BPVS, British Picture Vocabulary Scale (Dunn et al., 1982); bvFTD, patient group with behavioural variant frontotemporal dementia; C9orf72, pathogenic mutation in open reading frame of chromosome 9; Controls, healthy control group; D-KEFS, Delis Kaplan Executive System (Fine & Delis, 2011); GDA, Graded Difficulty Arithmetic test (Jackson & Warrington, 1986); GNT, Graded Naming Test (McKenna & Warrington, 1980); GRN, pathogenic mutation in progranulin gene; MAPT, pathogenic mutation in microtubule-associated protein tau gene; MMSE, Mini-Mental State Examination score (Folstein et al., 1975); nfvPPA, patient group with nonfluent – agrammatic variant primary progressive aphasia; RMT, Recognition Memory Test (Warrington, 1984); svPPA, patient group with semantic variant primary progressive aphasia; Trails-making task based on maximum time achievable (2.5 min on task A, 5 min on task B) (Lezak et al., 2004); VOSP, Visual Object and Spatial Perception Battery – Object Decision test (Warrington & James, 1991); WASI, Wechsler Abbreviated Scale of Intelligence (Wechsler, 1997).
Statistically significantly less than AD group.
Statistically significantly less than nfvPPA group.
Statistically significantly less than svPPA.
Statistically significantly less than bvFTD (all Pbonf<.05).
Fig. 1Individual data plots for identification accuracy and affective valuation for each laughter condition, across participant groups. The panels represent experimental laughter conditions (mirthful, hostile, posed) and the spectrally inverted laughter (inverted) control condition. Plotted on each panel are individuals' raw laughter identification accuracy scores (indexed as the unbiased hit rate) or affective valence ratings (on a 5-point Likert scale: 1, very unpleasant; 5, very pleasant) within each participant group. AD, patient group with typical Alzheimer's disease; BV, patient group with behavioural variant frontotemporal dementia; HC, healthy control group; NFV, patient group with nonfluent-agrammatic variant primary progressive aphasia; SV, patient group with semantic variant primary progressive aphasia.
Fig. 2Identification accuracy and affective valuation of laughter conditions: patient groups versus healthy controls. The panels represent experimental laughter conditions (mirthful, hostile, posed) and the spectrally inverted laughter (inverted) control condition. Plotted on each panel are mean differences (with 95% confidence intervals, adjusted for multiple comparisons with Bonferroni correction of p-values) in unbiased hit rates [Hu] (top panels) or rated valence (bottom panels) between each patient group and the healthy control group. Numerical data are presented in Supplementary Tables S1 and S4. The horizontal dashed line on each panel indicates the zero level corresponding to no difference between patient group and heathy control group. AD, patient group with typical Alzheimer's disease; BV, patient group with behavioural variant frontotemporal dementia; HC, healthy control group; NFV, patient group with nonfluent-agrammatic variant primary progressive aphasia; SV, patient group with semantic variant primary progressive aphasia.
Fig. 3Cognitive labelling of each laughter condition, across participant groups. Participant group profiles of laughter labelling are shown in separate panels corresponding to each ‘target’ laughter condition. Percentages of each response given (averaged across all participants within each group) are indicated; response categories are coded as colours: white, ‘mirthful’; black, ‘hostile’; grey, ‘posed’. Raw data are presented in Supplementary Table S3. AD, patient group with typical Alzheimer's disease; bvFTD, patient group with behavioural variant frontotemporal dementia; Controls, healthy control group; nfvPPA, patient group with nonfluent-agrammatic variant primary progressive aphasia; SD, standard deviation; svPPA, patient group with semantic variant primary progressive aphasia.
Fig. 4Affective valuation of spoken numbers by participant groups and in patients versus healthy controls. In the left panel, individual participants' average affective valence ratings of spoken numbers are plotted within each participant group. The right panel shows mean differences (with 95% confidence intervals, adjusted for multiple comparisons with Bonferroni correction of p-values) in rated valence between each patient group and the healthy control group; the horizontal dashed line indicates the zero level corresponding to no difference between patient group and heathy control group. AD, patient group with typical Alzheimer's disease; BV, patient group with behavioural variant frontotemporal dementia; HC, healthy control group; NFV, patient group with nonfluent-agrammatic variant primary progressive aphasia; SV, patient group with semantic variant primary progressive aphasia.
Neuroanatomical associations of laughter identification in the combined patient cohort.
| Contrast | Region | Side | Cluster | Peak | T score | PFWE | ||
|---|---|---|---|---|---|---|---|---|
| x | y | z | ||||||
| Overall | Inferior frontal gyrus: pars orbitalis | L | 119 | −34 | 21 | −12 | 7.29 | <.001 |
| Anterior insula | L | 183 | −39 | 4 | 6 | 6.37 | .002 | |
| R | 49 | 36 | 8 | 8 | 5.77 | .010 | ||
| Posterior insula | L | 18 | −40 | −6 | 8 | 5.61 | .016 | |
| Anteromedial prefrontal cortex | L | 17 | −4 | 39 | 40 | 5.78 | .010 | |
| Medio-dorsal thalamus | L | 23 | 0 | −16 | 3 | 5.69 | .013 | |
| Mirthful | Inferior frontal gyrus: pars orbitalis | L | 2350 | −36 | 21 | −10 | 9.41 | <.001 |
| Anterior insula | R | 998 | 42 | 21 | −6 | 7.05 | <.001 | |
| Dorsal anterior cingulate cortex | L | 33 | −4 | 9 | 44 | 6.37 | .002 | |
| Posterior middle temporal gyrus | L | 15 | −50 | −64 | 14 | 5.77 | .01 | |
| Hostile | Anterior insula | L | 267 | −39 | 6 | 4 | 7.00 | <.001 |
| R | 11 | 40 | 3 | 6 | 5.46 | .002 | ||
| Inferior frontal gyrus: pars orbitalis | L | 84 | −34 | 20 | −12 | 6.80 | <.001 | |
| Posterior insula | R | 27 | 40 | −8 | 10 | 5.77 | .01 | |
| Orbitofrontal cortex | L | 14 | −33 | 12 | −18 | 5.63 | .015 | |
| Posed | Anteromedial prefrontal cortex | L | 24 | −3 | 45 | 28 | 6.57 | <.001 |
| 30 | −4 | 39 | 40 | 5.68 | .012 | |||
| Inferior frontal gyrus: pars orbitalis | L | 50 | −34 | 21 | −12 | 6.35 | .002 | |
| Anterior cingulate cortex | L | 64 | −6 | 40 | 21 | 6.10 | .003 | |
| Orbitofrontal cortex | L | 61 | −27 | 28 | −22 | 5.83 | .008 | |
| Anterior insula | L | 47 | −42 | 3 | 3 | 5.79 | .009 | |
Significant regional grey matter associations of overall laughter identification accuracy and unbiased hit rates (see text) for each laughter condition over the combined patient cohort, based on voxel-based morphometry. All clusters with extent larger than 10 voxels are shown. Coordinates of local maxima are in standard Montreal Neurological Institute space. p values were all significant (<.05) after family-wise error (FWE) correction for multiple voxel-wise comparisons over the whole brain.
Fig. 5Neuroanatomical associations of laughter identification accuracy across the patient cohort. Statistical parametric maps (SPMs) of regional grey matter volume positively associated with overall laughter identification accuracy and accuracy of identification of particular laughter subtypes (derived from a voxel-based morphometric analysis) are shown for the combined patient cohort (see also Table 2). SPMs are overlaid on representative sections of the normalised study-specific T1-weighted group mean brain MR image, thresholded at p < .05FWE corrected for multiple voxel-wise comparisons over the whole brain. The MNI coordinate (mm) of the plane of each section is indicated and the left cerebral hemisphere is shown on the left for coronal sections and at the top for axial sections; the colour bars code T values for each SPM.
Fig. 6Syndromic profiles of cognitive and affective responses to laughter. The figure summarises the cognitive (laughter identification, ID) and affective (valence rating, face icon) responses to laughter subtypes (M, mirthful; H, hostile; P, posed; I, spectrally inverted) in the four dementia syndromes studied here. Shaded cells indicate a significantly abnormal alteration of laughter processing, coded as follows: white, no impairment; light grey, relative to healthy controls; dark grey, relative to the other disease group (FTD vs AD); black, relative to other syndromes within the FTD spectrum (see text and Supplementary Tables S1 and S4 for details). AD, patient group with typical Alzheimer's disease; bvFTD, patient group with behavioural variant frontotemporal dementia; nfvPPA, patient group with nonfluent-agrammatic variant primary progressive aphasia; svPPA, patient group with semantic variant primary progressive aphasia.